A detailed history of ETF Managers Group, LLC transactions in Dexcom Inc stock. As of the latest transaction made, ETF Managers Group, LLC holds 5,643 shares of DXCM stock, worth $639,803. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,643
Previous 5,559 1.51%
Holding current value
$639,803
Previous $629,000 4.13%
% of portfolio
0.02%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

BUY
$104.0 - $122.92 $8,736 - $10,325
84 Added 1.51%
5,643 $655,000
Q4 2022

Mar 23, 2023

SELL
$84.98 - $122.67 $117,357 - $169,407
-1,381 Reduced 19.9%
5,559 $629,000
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $136,208 - $168,017
1,784 Added 34.6%
6,940 $558,000
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $141,283 - $276,145
2,078 Added 67.51%
5,156 $389,000
Q1 2022

May 13, 2022

SELL
$94.08 - $130.2 $1.16 Million - $1.6 Million
-12,310 Reduced 80.0%
3,078 $1.6 Million
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $1.2 Million - $1.51 Million
9,251 Added 150.74%
15,388 $8.33 Million
Q3 2021

Nov 15, 2021

SELL
$106.71 - $143.18 $682,944 - $916,352
-6,400 Reduced 51.05%
6,137 $3.35 Million
Q2 2021

Aug 16, 2021

BUY
$80.99 - $107.93 $916,806 - $1.22 Million
11,320 Added 930.16%
12,537 $5.35 Million
Q1 2021

May 17, 2021

BUY
$84.79 - $104.74 $16,025 - $19,795
189 Added 18.39%
1,217 $423,000
Q4 2020

Feb 16, 2021

SELL
$78.0 - $104.5 $104,754 - $140,343
-1,343 Reduced 56.64%
1,028 $373,000
Q3 2020

Nov 16, 2020

BUY
$95.51 - $112.95 $30,372 - $35,918
318 Added 15.49%
2,371 $954,000
Q2 2020

Aug 14, 2020

SELL
$62.68 - $105.34 $245,517 - $412,616
-3,917 Reduced 65.61%
2,053 $818,000
Q1 2020

May 14, 2020

SELL
$47.79 - $75.63 $46,212 - $73,134
-967 Reduced 13.94%
5,970 $1.66 Million
Q4 2019

Feb 14, 2020

SELL
$36.62 - $57.29 $60,789 - $95,101
-1,660 Reduced 19.31%
6,937 $1.5 Million
Q3 2019

Nov 14, 2019

BUY
$35.53 - $43.8 $246,222 - $303,534
6,930 Added 415.72%
8,597 $1.28 Million
Q2 2019

Aug 14, 2019

SELL
$27.84 - $38.92 $7,294 - $10,197
-262 Reduced 13.58%
1,667 $243,000
Q1 2019

May 07, 2019

BUY
$28.07 - $38.18 $4,238 - $5,765
151 Added 8.49%
1,929 $230,000
Q4 2018

Feb 01, 2019

BUY
$26.99 - $37.37 $7,071 - $9,790
262 Added 17.28%
1,778 $213,000
Q3 2018

Nov 14, 2018

BUY
$23.35 - $36.72 $3,689 - $5,801
158 Added 11.63%
1,516 $217,000
Q2 2018

Aug 14, 2018

BUY
$17.54 - $25.22 $9,348 - $13,442
533 Added 64.61%
1,358 $55,000
Q1 2018

May 15, 2018

BUY
$13.06 - $18.54 $1,332 - $1,891
102 Added 14.11%
825 $61,000
Q4 2017

Feb 14, 2018

BUY
$11.12 - $15.38 $1,134 - $1,568
102 Added 16.43%
723 $42,000
Q3 2017

Nov 14, 2017

BUY
$11.36 - $18.98 $7,054 - $11,786
621
621 $30,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $43.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.